We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

100 hedge funds and large institutions have $64M invested in Sanofi Contingent Value Rights in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $57.4M → $64M (+$6.63M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 105 → 100 (-5)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

50% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 16

Holders
100
Holders Change
-5
Holders Change %
-4.76%
% of All Funds
2.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
8
Reduced
16
Closed
16
Calls
$612K
Puts
–
Net Calls
+$612K
Net Calls Change
+$21K

Top Buyers

Rank Fund Capital Flow
1
NGA
New Generation Advisors
Massachusetts
+$241K
2
HCM
Highbridge Capital Management
New York
+$161K
3
PC
Permanens Capital
New York
+$45.5K
4
TSS
Two Sigma Securities
New York
+$10.8K
5
Goldman Sachs
Goldman Sachs
New York
+$2.59K

Top Sellers

Rank Fund Capital Flow
1
BRF
B. Riley Financial
California
-$76K
2
First Eagle Investment Management
First Eagle Investment Management
New York
-$56K
3
BMO
Beck Mack & Oliver
New York
-$50.9K
4
UOC
UBS O'Connor
Illinois
-$31.1K
5
Citadel Advisors
Citadel Advisors
Florida
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$67K +$227 +565 +0.4%
YCM
27
Yakira Capital Management
Connecticut
$66K – – –
AL
28
Arnhold LLC
New York
$62K +$58.9K +146,402 New
PC
29
Permanens Capital
New York
$48K +$45.5K +112,982 New
UBS Group
30
UBS Group
Switzerland
$33K -$5.48K -13,619 -15%
GI
31
GAMCO Investors
Connecticut
$27K – – –
Korea Investment Corp
32
Korea Investment Corp
South Korea
$21K – – –
ZIG
33
Zuckerman Investment Group
Illinois
$18K – – –
DBG
34
De Burlo Group
Massachusetts
$16K – – –
Ameriprise
35
Ameriprise
Minnesota
$15K -$342 -850 -2%
CHAM
36
Clear Harbor Asset Management
Connecticut
$14K – – –
Morgan Stanley
37
Morgan Stanley
New York
$14K +$261 +649 +2%
SDWMA
38
Schneider Downs Wealth Management Advisors
Pennsylvania
$11K – – –
TSS
39
Two Sigma Securities
New York
$11K +$10.8K +26,820 New
Commonwealth Equity Services
40
Commonwealth Equity Services
Massachusetts
$9K +$49 +123 +0.5%
CS
41
Credit Suisse
Switzerland
$8K – – –
Bank of America
42
Bank of America
North Carolina
$7K -$72 -178 -1%
HK
43
Horizon Kinetics
New York
$7K – – –
MC
44
Moors & Cabot
Massachusetts
$7K – – –
BIA
45
Biondo Investment Advisors
Pennsylvania
$6K -$80 -200 -1%
FHA
46
Flagship Harbor Advisors
Massachusetts
$6K – – –
ISL
47
Ingalls & Snyder LLC
New York
$6K – – –
RJA
48
Raymond James & Associates
Florida
$5K -$40 -100 -0.9%
BlackRock
49
BlackRock
New York
$5K – – –
PNC Financial Services Group
50
PNC Financial Services Group
Pennsylvania
$4K -$137 -340 -4%
1
2
3 4

GCVRZ Hedge Fund Activity: Q1 2018 in Review

100 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2018, worth a combined $64M — up 12% from $57.4M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 12 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 8 added.

The largest buyer was New Generation Advisors, adding an estimated $241K. The largest seller was B. Riley Financial, exiting entirely with an estimated $76K sold.

  • 100 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2018, down from 105 in Q4 2017.
  • Funds reported $64M of Sanofi Contingent Value Rights stock for Q1 2018, up 12% quarter-over-quarter.
  • 12 funds opened new Sanofi Contingent Value Rights positions in Q1 2018 and 16 closed out, a net change of -4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2018 was New Generation Advisors, an estimated $241K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2018 was B. Riley Financial, an estimated $76K sold.

Based on aggregated 13F filings for Q1 2018.